CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19
Clinical trial NCT04575038 · COMPLETED
Trial details
- NCT number
- NCT04575038
- Sponsor
- Clear Creek Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2021-04-28
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.